| abstract |
Disclosed herein is a use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically those compounds of the formula (I), (wherein X1 is H, alkoxy or alkyl; X2 and X3 are H, halo, alkyl or as defined in the specification; and Q is an N-containing saturated heterocyclic group as shown in the specification) or their pharmaceutically acceptable salts, for treating various CNS and other disorders. |